Pictogram | Signal | Statements | Precautionary Statement Codes |
---|---|---|---|
Danger |
Aggregated GHS information provided by 42 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral] H310 (100%): Fatal in contact with skin [Danger Acute toxicity, dermal] H330 (100%): Fatal if inhaled [Danger Acute toxicity, inhalation] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P260, P262, P264, P270, P271, P280, P284, P301+P310, P302+P350, P304+P340, P310, P320, P321, P322, P330, P361, P363, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) | |
Organism | Test type | Route | Dose (normalized dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 18mg/kg (18mg/kg) | "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980Vol. 6, Pg. 168, 1981. | |
rat | LDLo | oral | 10mg/kg (10mg/kg) | Experientia. Vol. 30, Pg. 135, 1974. | |
(1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-6,11,16-trioxo-13,17-dioxapentacyclo[10.6.1.0^{2,10}.0^{5,9}.0^{15,19}]nonadeca-2(10),12(19),14-trien-3-yl acetate | (1R,6bR,9aS,11R,11bR)-1-(methoxymethyl)-9a,11b-dimethyl-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b- decahydro-3H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate | (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4, |
(1S,6bR,9aS,11R,11bR)-1-(methoxymethyl)-9a,11b-dimethyl-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate | (1S,6bR,9aS,11R,11bR)-1-(methoxymethyl)-9a,11b-dimethyl-3,6,9-trioxo-3,6,6b,7,8,9,9a,10,11,11b-decahydro-1H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate | (1S,6bR,9aS,11R,11bR)-9a,11b-dimethyl-1-[(methyloxy)methyl]-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate |
(1alpha,11alpha)-11-(Acetyloxy)-1-(methoxymethyl)-2-oxaandrosta-5,8-dieno(6,5,4-bc)furan-3,7,17-trione | 19545-26-7 | 2-Oxaandrosta-5,5,4-bc]furan-3,7,17-trione, 11-(acetyloxy)-1-(methoxymethyl)-, (1.alpha.,11.alpha.)- |
2100AH | 2803AH | 3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE |
3H-Furo[4,2-de]indeno[4,5,-h]-2-benzopyran-3,6,9-trione, 11-(Acetyloxy)-1,6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-, (1S,6br,9aS,11R,11bR) | 3H-Furo[4,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione, 11-(acetyloxy)-1,6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-, (1S,6br,9aS,11R,11bR) | 3H-Furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione, 11-(acetyloxy)-1,6b,7,8,9a,10,11,11b- |
3H-Furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione,11-(acetyloxy)-1,6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-, (1S,6bR,9aS,11R,11bR)- | 3H-furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione, 11-(acetyloxy)-1, | 4-19-00-03134 (Beilstein Handbook Reference) |
44665-EP2277881A1 | 44665-EP2277898A2 | 44665-EP2292227A2 |
44665-EP2301533A1 | 44665-EP2311818A1 | 6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-, (1S,6bR,9aS,11R,11bR)- |
ACon0_000951 | Antibiotic SL-2052 | BDBM15234 |
BIW4201 | BRD-K87343924-001-02-4 | BRN 0067676 |
BS-16306 | BSPBio_001232 | C15181 |
C23H24O8 | CCG-208290 | CHEBI:52289 |
CHEMBL428496 | CS-5073 | CU-00000000011-1 |
DB08059 | DTXSID8040642 | EX-A1930 |
GTPL6060 | HMS1792N13 | HMS1990N13 |
HMS3403N13 | HY-10197 | J-012661 |
KS-00001CQL | KY 12420 | KY-12420 |
KY-12420 | KY12420 | MEGxm0_000446 |
MFCD00133927 | MLS002703028 | NCGC00163485-01 |
NCGC00163485-02 | NCI60_001835 | NSC 627609 |
NSC-221019 | NSC-627609 | NSC221019 |
NSC627609 | Pi 3-Kinase Inhibitor | SCHEMBL4531 |
SL-2052 | SL-2052 | SMR001566836 |
ST-415 | UNII-XVA4O219QW | Wartmannin |
Wortmannin | Wortmannin solution, 100 mug/mL in acetonitrile, analytical standard | Wortmannin, 98% |
Wortmannin, Wm | Wortmannin, from Penicillium funiculosum | Wortmannin, from Penicillium funiculosum, >=98% (HPLC and TLC) |
Wortmannin,Penicillium wortmannin | XVA4O219QW | ZINC1619592 |
ZX-AFC000406 | cid_312145 | nchembio866-comp1 |
octahydro-1-(methoxymethyl)-9a,11b-dimethyl-, [1S-(1alpha,6baalpha,9abeta,11alpha,11bbeta)]- | s2758 | wortmanin |
wortmannin |